Home › Kanser sa Prostate › Virginia › Arlington
Pag-aaral pangklinika para sa Kanser sa Prostate sa Arlington, VA
Isang pag-aaral para sa Kanser sa Prostate ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Arlington. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Nagre-recruitPhase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi ang layo
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Nagre-recruitPhase 3
- Inova Schar Cancer Institute ( Site 0017), Fairfax · 11 mi ang layo
- Virginia Cancer Specialists (VCS) ( Site 8004), Fairfax · 11 mi ang layo
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Nagre-recruitPhase 2/3
- Virginia Cancer Specialists, Fairfax · 11 mi ang layo
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Nagre-recruitPhase 1
- Investigational Site number: 404, Fairfax · 11 mi ang layo
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
- NEXT Oncology, Fairfax · 11 mi ang layo
The Vanguard Study: Testing a New Way to Screen for Cancer
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Inova Schar Cancer Institute, Fairfax · 11 mi ang layo
- Inova Fair Oaks Hospital, Fairfax · 11 mi ang layo
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
Nagre-recruitPhase 2
- Virginia Cancer Specialists, Fairfax · 11 mi ang layo
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Nagre-recruitPhase 1
- Virginia Cancer Specialists PC, Fairfax · 11 mi ang layo
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Nagre-recruitPhase 1/2
- NEXT Oncology - Virginia, Fairfax · 11 mi ang layo
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Nagre-recruitPhase 1
- Virginia Oncology Associates, Fairfax · 11 mi ang layo
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
Nagre-recruit
- Inova Schar Cancer Institute, Fairfax · 11 mi ang layo
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
Nagre-recruitPhase 1/2
- NEXT Oncology, Fairfax · 11 mi ang layo
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1
- NEXT Oncology Virginia, Fairfax · 11 mi ang layo
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Nagre-recruitPhase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi ang layo
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Nagre-recruitPhase 1/2
- NEXT, Virginia, Fairfax · 11 mi ang layo
Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture
Nagre-recruit
- Inova Schar Cancer Institute, Fairfax · 11 mi ang layo
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Research Site 102, Fairfax · 11 mi ang layo
- Research Site 112, Fairfax · 11 mi ang layo
Pag-aaral para sa Kanser sa Prostate sa ibang lungsod
- New York City, NY103 pag-aaral
- Houston, TX76 pag-aaral
- Los Angeles, CA61 pag-aaral
- Boston, MA59 pag-aaral
- St. Louis, MO46 pag-aaral
- Chicago, IL45 pag-aaral
- San Francisco, CA45 pag-aaral
- Philadelphia, PA44 pag-aaral
- Baltimore, MD43 pag-aaral
- Nashville, TN42 pag-aaral
- Seattle, WA42 pag-aaral
- Washington, DC38 pag-aaral
Iba pang pag-aaral sa Arlington
- Non-Small Cell Lung Cancer104 pag-aaral
- Metastatic Cancer53 pag-aaral
- Colorectal Cancer52 pag-aaral
- Kanser (lahat ng uri)48 pag-aaral
- Kanser sa Suso46 pag-aaral
- Kanser sa Ovary46 pag-aaral
- Kanser sa Baga41 pag-aaral
- Kanser ng Endometrium39 pag-aaral
- Kanser sa Pancreas33 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg26 pag-aaral
- Small Cell Lung Cancer23 pag-aaral
- Triple-Negative Breast Cancer20 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.